Glenmede Total Market Plus Equity Portfolio (GTTMX)
18.94
-0.09
(-0.47%)
USD |
May 19 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 2.04% | 30.74M | -- | 70.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -10.20M | 11.66% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation consistent with reasonable risk to principal. Using quantitative analysis, the Portfolio invests at least 80% of the value of its net assets in long and short positions with respect to equity securities, such as common stocks, of public companies tied economically to the US. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | Alternative |
| Broad Category | Alternative |
| Global Peer Group | Equity US |
| Peer Group | Alternative Active Extension Funds |
| Global Macro | Equity North America |
| US Macro | Alternative Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Alternative Long/Short Equity Funds |
| Fund Owner Firm Name | Glenmede Funds |
| Broad Asset Class Benchmark Index | |
| ^MSACWINTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
60
-15.51M
Peer Group Low
32.48M
Peer Group High
1 Year
% Rank:
92
-10.20M
-43.31M
Peer Group Low
798.80M
Peer Group High
3 Months
% Rank:
60
-73.76M
Peer Group Low
120.88M
Peer Group High
3 Years
% Rank:
84
-168.12M
Peer Group Low
353.16M
Peer Group High
6 Months
% Rank:
86
-31.72M
Peer Group Low
569.12M
Peer Group High
5 Years
% Rank:
42
-1.925B
Peer Group Low
134.36M
Peer Group High
YTD
% Rank:
60
-54.89M
Peer Group Low
299.45M
Peer Group High
10 Years
% Rank:
34
-14.02B
Peer Group Low
134.36M
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 20, 2025.
Asset Allocation
As of January 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.52% |
| Stock | 99.48% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Stride Inc | 3.24% | 157.38 | 0.27% |
| Merit Medical Systems Inc | 2.80% | 98.84 | 0.75% |
| MGIC Investment Corp | 2.78% | 26.61 | -0.34% |
| eBay Inc | 2.70% | 72.58 | 0.21% |
| Unum Group | 2.66% | 82.02 | -0.17% |
| Catalyst Pharmaceuticals Inc | 2.66% | 24.70 | 0.26% |
| Sanmina Corp | 2.59% | 82.31 | 1.16% |
| F5 Inc | 2.52% | 286.70 | 0.35% |
| Hims & Hers Health Inc | 2.47% | 61.15 | -1.91% |
| Genpact Ltd | 2.46% | 44.43 | 0.75% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.73% |
| Administration Fee | 52.32K% |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 1000.00 None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation consistent with reasonable risk to principal. Using quantitative analysis, the Portfolio invests at least 80% of the value of its net assets in long and short positions with respect to equity securities, such as common stocks, of public companies tied economically to the US. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | Alternative |
| Broad Category | Alternative |
| Global Peer Group | Equity US |
| Peer Group | Alternative Active Extension Funds |
| Global Macro | Equity North America |
| US Macro | Alternative Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Alternative Long/Short Equity Funds |
| Fund Owner Firm Name | Glenmede Funds |
| Broad Asset Class Benchmark Index | |
| ^MSACWINTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (5-19-25) | 0.14% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 22.68 |
| Weighted Average Price to Sales Ratio | 3.293 |
| Weighted Average Price to Book Ratio | 3.692 |
| Weighted Median ROE | 71.53% |
| Weighted Median ROA | 8.24% |
| ROI (TTM) | 12.56% |
| Return on Investment (TTM) | 12.56% |
| Earning Yield | 0.0602 |
| LT Debt / Shareholders Equity | 0.6825 |
As of January 31, 2025
Growth Metrics
| EPS Growth (1Y) | 23.23% |
| EPS Growth (3Y) | 26.41% |
| EPS Growth (5Y) | 16.00% |
| Sales Growth (1Y) | 6.26% |
| Sales Growth (3Y) | 12.06% |
| Sales Growth (5Y) | 10.91% |
| Sales per Share Growth (1Y) | 7.75% |
| Sales per Share Growth (3Y) | 12.26% |
| Operating Cash Flow - Growth Ratge (3Y) | 16.01% |
As of January 31, 2025
Fund Details
| Key Dates | |
| Inception Date | 12/21/2006 |
| Last Annual Report Date | 10/31/2024 |
| Last Prospectus Date | 2/28/2025 |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | No |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | No |
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:GTTMX", "name") |
| Broad Asset Class: =YCI("M:GTTMX", "broad_asset_class") |
| Broad Category: =YCI("M:GTTMX", "broad_category_group") |
| Prospectus Objective: =YCI("M:GTTMX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |